Promising vaccine strategy for type 1 diabetes extended to humans

March 23, 2015, National Jewish Health

A molecule that prevents Type 1 diabetes in mice has provoked an immune response in human cells, according to researchers at National Jewish Health and the University of Colorado. The findings, published online in the Proceedings of the National Academy of Sciences, suggest that a mutated insulin fragment could be used to prevent Type 1 diabetes in humans.

"The incidence of Type 1 is increasing dramatically," said John Kappler, PhD, professor of Biomedical Research at National Jewish Health. "Our findings provide an important proof of concept in humans for a promising vaccination strategy."

Type 1 diabetes is an autoimmune disease in which the immune system destroys the body's ability to produce insulin, a hormone essential for sugar metabolism. Researchers have tried administering insulin to people at risk for the disease as a form of immunotherapy similar to allergy shots. None of the trials has provoked an effective response.

The most recent findings suggest that an insulin fragment with a change to a single amino acid could provoke that elusive immune response. The idea for the substitution comes from more than a decade of work in Dr. Kappler's lab detailing the molecular minutiae of the immune system's response to insulin. This work suggests that insulin is presented to the immune system in an unconventional manner, and that mutating one amino acid in an insulin fragment might provoke better recognition by the immune system.

In 2011, a team from Harvard University and the Dana Farber Cancer Institute reported that the strategy suggested by Dr. Kappler and his colleagues did indeed prevent in mice. Mice and humans, however, differ in many ways, and strategies that work in mice often fail to produce any response in humans.

In their current paper, Dr. Kappler, Aaron Michels, MD, at the Barbara Davis Center for Childhood Diabetes, and their colleagues mixed the naturally occurring insulin fragment and the mutated insulin fragment with separate cultures of human cells. They found that human T cells responded minimally to the naturally occurring insulin fragment but quite strongly o the mutated one. The human T cells produced both pro-inflammatory and anti-inflammatory chemicals known as cytokines.

Researchers believe healthy responses balance pro- and anti-inflammatory factors. Autoimmune disease occurs when the pro-inflammatory response dominates.

While the current results do not prove that the mutated insulin fragment will work as a vaccine in humans, they do demonstrate a response in humans consistent with the vaccination response in mice. Some of the signals seen in are associated T regulatory cells, which can dampen the and hold it in check.

"The new findings confirm that the painstaking work we have done to understand the unconventional interaction of insulin and the has relevance in humans and could lead to a vaccine and a treatment for diabetes," said Dr. Kappler. "We are eager to push this promising line of inquiry forward."

Explore further: New compound prevents onset of type 1 diabetes in animal models

More information: Regulatory vs. inflammatory cytokine T-cell responses to mutated insulin peptides in healthy and type 1 diabetic subjects, PNAS,

Related Stories

New compound prevents onset of type 1 diabetes in animal models

March 17, 2015
Scientists from the Florida campus of The Scripps Research Institute (TSRI) have successfully tested a potent synthetic compound that prevents type 1 diabetes in animal models of the disease.

Researchers prevent type 1 diabetes in lab

January 20, 2015
In new research published in Endocrinology, Thomas Burris, Ph.D., chair of pharmacological and physiological science at Saint Louis University, reports that his team has found a way to prevent type I diabetes in an animal ...

Moving towards a better treatment for autoimmune diabetes

April 9, 2012
Insulin is required for the regulation of blood sugar levels. In type I diabetes, the cells that produce insulin are destroyed by the immune system.

Molecular link between obesity and type 2 diabetes reveals potential therapy

February 23, 2015
Obesity causes inflammation, which can in turn lead to type 2 diabetes. What isn't well established is how inflammation causes diabetes—or what we can do to stop it. Researchers at University of California, San Diego School ...

Novel type 1 diabetes treatment shown to work on human beta cells transplanted into mice

November 25, 2014
A chemical produced in the pancreas that prevented and even reversed Type 1 diabetes in mice had the same effect on human beta cells transplanted into mice, new research has found.

Recommended for you

High gluten diet in pregnancy linked to increased risk of diabetes in children

September 19, 2018
A high gluten intake by mothers during pregnancy is associated with an increased risk of their child developing type 1 diabetes, suggests a study published by The BMJ today.

Anti-inflammatory protein promotes healthy gut bacteria to curb obesity

September 19, 2018
Scientists from the UNC School of Medicine discovered that the anti-inflammatory protein NLRP12 normally helps protect mice against obesity and insulin resistance when they are fed a high-fat diet. The researchers also reported ...

Study reveals the current rates of diagnosed type 1 and type 2 diabetes in American adults

September 18, 2018
A new study from the University of Iowa finds that type 2 diabetes remains overwhelmingly the most common type of diabetes diagnosed in American adults who have the disease.

Research reveals link between immunity, diabetes

September 14, 2018
When it comes to diet-induced obesity, your immune system is not always your friend.

BPA exposure in U.S.-approved levels may alter insulin response in non-diabetic adults

September 14, 2018
In a first study of its kind study, researchers have found that a common chemical consumers are exposed to several times a day may be altering insulin release. Results of the study, led by scientists at the University of ...

High blood sugar during pregnancy ups risk of mother's type 2 diabetes, child's obesity

September 11, 2018
Mothers with elevated blood glucose during pregnancy—even if not high enough to meet the traditional definition of gestational diabetes—were significantly more likely to have developed type 2 diabetes a decade after pregnancy ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.